Search clinical trials for: ABT-143 (rosuvastatin calcium and fenofibric acid )

Total 2526 results

Bangabandhu Sheikh Mujib Medical University, Dhaka...

Unknown

A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia

Hyperlipidemia

Bangladesh
Severance Hospital
AstraZeneca

Terminated

The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke (EUREKA)

Stroke

Korea, Republic of
Government Dental College and Research Institute...

Completed

Efficacy of Locally Delivred 1.2% Rosuvastatin Gel in Chronic Periodontitis

Chronic Periodontitis
Kleber Bomfim Araujo Martins

Unknown

Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention (CLEAR-PCI)

Coronary Artery Disease

Brazil
Canadian Critical Care Trials Group
Canadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated... and other collaborators

Terminated

Collaborative H1N1 Adjuvant Treatment Pilot Trial (CHAT)

Critically Ill | H1N1/Influenza Infection

Canada
National Taiwan University Hospital

Available

A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome

Diabetes | CVD
AstraZeneca

Completed

Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study

Heart Failure | Rosuvastatin | Positron Emission Tomography (PET)

Netherlands
Universidad Autonoma de San Luis Potosí
AstraZeneca; Hospital Central "Dr. Ignacio Morones Prieto"

Completed

Effect of Rosuvastatin on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Moderate Head Injury

Head Injury

Mexico
AstraZeneca

Completed

Effects of Crestor on Inflammation of Atherosclerotic Plaques

Atherosclerosis | Inflammatory Activity in Carotid Arteries

Sweden
AstraZeneca

Completed

Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg (EXPLORER)

Atherosclerosis | Hypercholesterolemia | Coronary Heart Disease
AstraZeneca

Completed

Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

Coronary Artery Disease | Myocardial Ischaemia
Brigham and Women's Hospital

Completed

Rho Kinase in Patients With Atherosclerosis

Atherosclerosis

United States
Washington University School of Medicine

Recruiting

Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes | Clonal Cytopenia of Undetermined Significance

United States
Loxo Oncology, Inc.
Eli Lilly and Company

Completed

A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy Participants

Healthy

United States
Minneapolis Heart Institute Foundation

Active, not recruiting

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial (DESIFOR)

Cardiovascular Diseases | Cardiovascular Risk Factor | Adverse Effect

United States
Helse Stavanger HF
University Hospital of North Norway; St. Olavs Hospital; Helse Vest

Completed

Microcirculation In Acute Coronary Syndromes (MICROS)

ST Elevation (STEMI) Myocardial Infarction

Norway
AstraZeneca

Completed

A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis

Atherosclerosis

China
Children's Mercy Hospital Kansas City

Completed

Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients (SD2)

Dyslipidemia

United States
Poxel SA

Completed

Safety, Tolerability and PK of PXL770 in Healthy Male Subjects

Metabolic Disease

United Kingdom
University of Vermont

Completed

Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) (DISOLVE)

Neoplasms | Deep Vein Thrombosis | Venous Thromboembolism

United States
AstraZeneca

Completed

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia (HYDRA)

Homozygous Familial Hypercholesterolemia (HoFH)

Malaysia, Canada, Israel, Netherlands, Taiwan, Belgium, Denmark
Queen's University
AstraZeneca

Completed

Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

Dyslipidemia | Acute Coronary Syndromes

Canada
Listen Trial Group

Completed

LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts (LISTEN)

Hypercholesterolemia With Concomitant Type 2 Diabetes

Japan
Svendborg Hospital
University of Southern Denmark

Unknown

Intensive Statin Therapy in Patients With AMI (INTENSIFY)

Acute Myocardial Infarction

Denmark
AstraZeneca

Completed

Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia

Hypercholesterolemia

China
University of Rome Tor Vergata

Completed

Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients

Type 2 Diabetes | Diabetic Dyslipidemia

Italy
AstraZeneca

Completed

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca

Completed

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

France, Italy, Spain, Estonia, Hungary, Canada, Belgium, Portugal, Greece, Ireland, Tunisia
Cairo University
German University in Cairo

Recruiting

Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

Cisplatin Adverse Reaction

Egypt
Bjarne Linde Noergaard

Recruiting

Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study) (FlowPromote)

Coronary Artery Disease

Denmark
Asan Medical Center
Dong-A ST Co., Ltd.

Completed

Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk (RESERVE II)

Hypertension

Korea, Republic of
Pfizer

Completed

A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics

Healthy Volunteers

Belgium
AstraZeneca
Eli Lilly and Company

Completed

A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin

Healthy

United States
National Cheng-Kung University Hospital

Completed

Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula

Diabetes Mellitus | Arteriovenous Fistula | End-stage Kidney Disease

Taiwan
GlaxoSmithKline

Completed

A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects

Diabetes Mellitus, Type 2

United States
RenJi Hospital

Unknown

Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke (AIS)

Ischemic
Pin Siang Medical Biotechnology Co., Ltd.

Unknown

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

Hypercholesterolemia

Taiwan
Peking University Third Hospital

Unknown

Peking and Rotterdam on Mission to Reduce Coronary Artery Disease (PROMISS)

Diabetes Mellitus | Acute Coronary Syndrome

China
AstraZeneca

Completed

Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease (PLANET II)

Hyperlipidemia

United States, Bulgaria, South Africa, Germany, Hungary, Romania, Canada, Denmark, Mexico, Italy, Brazil
Yokohama City University Medical Center

Unknown

The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris

Coronary Disease | Hypercholesterolemia

Japan
Universidad Autonoma de San Luis Potosí

Unknown

Effect of Rosuvastatin in Abdominal Sepsis

Sepsis

Mexico
AstraZeneca

Completed

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Hypercholesteremia

Belgium
Universidad Autonoma de San Luis Potosí

Completed

Effect of Rosuvastatin in Intracerebral Hemorrhage

Stroke | Intracerebral Hemorrhage

Mexico
Ramathibodi Hospital
AstraZeneca

Unknown

Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level

Systemic Lupus Erythematosus | High LDL Cholesterol Level

Thailand
AstraZeneca

Completed

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS) (HEROS)

Diabetes | Hypercholesterolemia | Coronary Heart Disease | Peripheral Vascular Disease | Cerebrovascular Accident
University of California, Davis
United States Department of Defense

Recruiting

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Metastatic Nonsmall Cell Lung Cancer

United States
Veloxis Pharmaceuticals

Withdrawn

A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo

Chemotherapy-induced Peripheral Neuropathy
Positive Trial Group

Terminated

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments (POSITIVE)

Hypertension | Type 2 Diabetes | Hypercholesterolemia

Japan
Radboud University Medical Center

Completed

Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury

Endothelial Dysfunction | Ischemia Reperfusion Injury

Netherlands
Yonsei University

Not yet recruiting

Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)

Peripheral Artery Disease | Polyvascular Disease

Korea, Republic of

3

Subscribe